Recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225 Conditions Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more Locations MPN Research Foundation — Chicago, Illinois, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
Completed Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm NCT01787487 Conditions Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +10 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis NCT04517851 Conditions Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +9 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
